Seminar “Advance HTA Project and its Implications for the Region of the Americas” – RedETSA

Seminar “Advance HTA Project and its Implications for the Region of the Americas”

The Department of Health Systems and Services, Unit of Medicines and Health Technologies of the Pan American Health Organization is organizing the Seminar “Advance HTA Project and its Implications for the Region of the Americas” to be held on January 21st, from 2:00 pm to 5:30pm, Washington, DC.
Professor Panos Kanavos from the London School of Economics and Political Science (LSE), will speak on the results of the project and lessons learned for the Region. The Advance HTA project was led by the LSE and brought together 13 members, from 11 countries, including PAHO. Its aim was to promote and strengthen the tools and practices concerning the application and implementation of HTA in the countries.
Interested parties may attend the same by WebEx using the following link: (English only)
Agenda – 21st January
14:30 Results of the Advance HTA Project (Panos Kanavos)
15:30 Questions and Answers
15:50 Break
16:10 HTA and Decision-Making in the Americas (Alexandre Lemgruber)
16:30 Potential Implications: Lessons Learned, Policy Recommendations and Advances in HTA (Panos Kanavos)
17:00 Discussion
17:30 Closing
Panos Kanavos (BSc, MSc, PhD) is Reader in International Health Policy in the Department of Social Policy, London School of Economics (LSE) and Programme Director of the Medical Technology Research Group (MTRG) at LSE Health.He has previously been Harkness Fellow in Health Care Policy in the Dept of Ambulatory Care and Prevention, Harvard Medical School. He is an Economist by training, currently coordinates the Programme in International Health Policy at LSE and teaches Health Economics, Pharmaceutical Economics and Policy, Health Care Financing, and Health Systems Performance Measurement.
Panos leads the activities of MTRG, which is a research unit comprising 11 researchers within LSE Health and concentrates on interdisciplinary and comparative policy research on medical technologies. The group has a number of research streams as follows:
– The economics of medical technologies, in particular, medicines and medical devices;
– Prescribing, appropriateness and quality of care;
– Access to medical technologies in developing and transition economies; and
– Disease management and policy effectiveness in medical technology.
As part of its activities, MTRG administers the Programme on Pharmaceutical Policy Issues (PPPI), the Programme on Medical Devices, conducts research under the auspices of and participates in the European Medicines Information Network (EMI-net), the network for the study of rare diseases (BURQOL-RD), and is a member of the European Health Technology Institute for Socio-Economic Research (EHTI). It also coordinates the activities of The Patient Academy, an initiative between academia, health care regulatory agencies and patient groups.
Panos has acted as an advisor to a number of international governmental and nongovernmental organizations, including the European Commission, the European Parliament, the World Bank, the World Health Organization, the Organization for Economic Co-operation and Development, the American Association for Retired Persons, and Ministries of Health of over 21 transition and developing countries. He has participated in the European Pharmaceutical Forum as advisor to the European Commission – DG Enterprise and has been involved in the Commission’s reflection process on the Economics of Medical Devices.